Waton Financial Limited Partners with Panda AI to Launch Global AI Trading Agent Competition to Accelerate AI Adoption Across Traditional Financial Institutions

Waton Financial Limited Partners with Panda AI to Launch Global AI Trading Agent Competition to Accelerate AI Adoption Across Traditional Financial Institutions GlobeNewswire November 20, 2025 HONG KONG, Nov. 20, 2025 (GLOBE NEWSWIRE) — Waton Financial Limited (NASDAQ: WTF), a provider of securities brokerage and financial technology services (“Waton” or the “Company”), today announced a […]

Marketwise Announces Financial and Legal Advisors of the Special Committee of its Board of Directors

Marketwise Announces Financial and Legal Advisors of the Special Committee of its Board of Directors GlobeNewswire November 20, 2025 BALTIMORE, Nov. 20, 2025 (GLOBE NEWSWIRE) — On October 29, 2025, MarketWise, Inc. (“MarketWise” or the “Company”) (NASDAQ: MKTW), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for

SAIC Secures $1.4 Billion COBRA Task Order to Fast-Track Warfighting Technologies from Concept to Combat

SAIC Secures $1.4 Billion COBRA Task Order to Fast-Track Warfighting Technologies from Concept to Combat Mission integrator will rapidly deliver next-gen capabilities that accelerate decision superiority, strengthen readiness and enhance lethality GlobeNewswire November 20, 2025 RESTON, Va., Nov. 20, 2025 (GLOBE NEWSWIRE) — America's leading mission integrator, Science Applications International Corp. (NASDAQ: SAIC), has been

RokuNana Opens on Manhattan’s Lower East Side, Blending Modern Sushi Izakaya with an Immersive Japanese Speakeasy Upstairs

RokuNana Opens on Manhattan's Lower East Side, Blending Modern Sushi Izakaya with an Immersive Japanese Speakeasy Upstairs GlobeNewswire November 20, 2025 NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — A new culinary destination has landed on the Lower East Side as RokuNana, a creative sushi bar and Japanese speakeasy, officially opens its doors this week.

Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025

Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025 GlobeNewswire November 20, 2025 NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in Shaare Zedek Medical Center show high safety profile

Commure Partners with Hughston Clinic to Transform Orthopedic Care with Enterprise AI Platform

Commure Partners with Hughston Clinic to Transform Orthopedic Care with Enterprise AI Platform Hughston Clinic to Leverage Commure's Robust Platform to Automate Workflows Across the Full Care Continuum GlobeNewswire November 20, 2025 MOUNTAIN VIEW, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Commure, a leading healthcare technology company, today announced a partnership with Hughston Clinic, one

Snail Inc. to Host Investor Day at the NASDAQ MarketSite on December 16, 2025

Snail Inc. to Host Investor Day at the NASDAQ MarketSite on December 16, 2025 Snail, Inc. to unveil significant updates to its Stablecoin initiative and upcoming ARK: Lost Colony DLC GlobeNewswire November 20, 2025 CULVER CITY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in Shaare Zedek Medical Center show high safety profile

Scroll to Top